Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Tectonic Therapeutic, Inc. publishes a filing, an earnings call transcript or a press release.

Get TECX alerts

About Marcella K. Ruddy

Tectonic Therapeutic, Inc. reported in an 8-K filed June 20, 2024 that Marcella K. Ruddy was appointed Chief Medical Officer, effective June 20, 2024. The proxy statement of Tectonic Therapeutic, Inc. reports total compensation of $3,069,630 for Marcella K. Ruddy in fiscal 2025, including a base salary of $501,050. Disclosed compensation is on record for 2 fiscal years. Marcella K. Ruddy has spoken on 1 investor event across 1 company, most recently for Tectonic Therapeutic, Inc. on October 29, 2025. Tectonic Therapeutic, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tectonic Therapeutic, Inc. includes Alise Reicin (CEO and Board Member), Alise Reicin, M.D. (CEO and Board Member), Erik Ostrowski (CEO) and 7 others.

“Marcella K. Ruddy, M.D. as the Chief Medical Officer”
Tectonic Therapeutic, Inc. Form 8-K, filed June 20, 2024 · Read the filing

Marcella K. Ruddy on recent calls

“So, what was the rationale for exploring TX45 in PHF breast patients? First, TX45 is a long-acting relaxant.”
Other, TX45 Phase 1b (Part B) PH-HFrEF Data Conference Call ·

Affiliation history

Company network

Leadership on record at Tectonic Therapeutic, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Tectonic Therapeutic, Inc. (TECX) $501,050 $3,069,630
2024 Tectonic Therapeutic, Inc. (TECX) $476,165 $1,840,892

Recent activity